Staff Publications: April 2018

  1. Abbas AM, Strong AT, Diehl DL, et al. Multicenter Evaluation of the Clinical Utility of Laparoscopy-Assisted Ercp in Patients with Roux-En-Y Gastric Bypass. Gastrointest Endosc. 2018;87(4):1031-1039. PMID: 29129525.
  2. Adolf-Bryfogle J, Kalyuzhniy O, Kubitz M, et al. Rosettaantibodydesign (RAbD): A General Framework for Computational Antibody Design. PLoS Comput Biol. 2018;14(4):e1006112. PMID: 29702641. PMC5942852.
  3. Autieri MV. Il-19 and Other Il-20 Family Member Cytokines in Vascular Inflammatory Diseases. Front Immunol. 2018;9:700. PMID: 29681905. PMC5897441.
  4. Benson AB, 3rd, Venook AP, Al-Hawary MM, et al. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359-369. PMID: 29632055.
  5. Borghaei H, Yim YM, Guerin A, et al. Severe Adverse Events Impact Overall Survival and Costs in Elderly Patients with Advanced Non-Small Cell Lung Cancer on Second-Line Therapy. Lung Cancer. 2018;119:112-119. PMID: 29656745.
  6. Cahn DB, Foote C, Smaldone MC. Challenges Facing Regionalization of Radical Cystectomy. Transl Androl Urol. 2018;7(2):292-294. PMID: 29733077. PMC5911529.
  7. Cohen SJ, Zalupski MM, Conkling P, et al. A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-Naive Pancreatic Adenocarcinoma. Am J Clin Oncol. 2018;41(3):230-235. PMID: 26709865.
  8. Correa AF, Smaldone MC. Melancholia and Cancer: The Bladder Cancer Narrative. Cancer. 2018;124(15):3080-3083. PMID: 29660788.
  9. Cueto R, Zhang L, Shan HM, et al. Identification of Homocysteine-Suppressive Mitochondrial Etc Complex Genes and Tissue Expression Profile – Novel Hypothesis Establishment. Redox Biol. 2018;17:70-88. PMID: 29679893. PMC6006524.
  10. Dolman GE, Koffas A, Mason WS, Kennedy PT. Why, Who and When to Start Treatment for Chronic Hepatitis B Infection. Curr Opin Virol. 2018;30:39-47. PMID: 29655092.
  11. Doss M. Radiation Dose from Cardiac Catheterization Procedures in Young Patients May Not Contribute to Increased Cancer Risk. Eur J Epidemiol. 2018;33(4):425-426. PMID: 29616389.
  12. Edwards DC, Cahn DB, Smaldone MC, Kutikov A. Use of Administrative Data for Comparative Effectiveness Research in the Treatment of Non-Prostate Genitourinary Malignancies. Urol Oncol. 2018;36(4):193-212. PMID: 28867432.
  13. Fahl SP, Wiest DL. Reply to Chien: Clarification of the Effect of Ligand on γδ-TCR Repertoire Selection. Proc Natl Acad Sci USA. 2018;115(16):E3607-E3608. PMID: 29615510. PMC5910880.
  14. Gajra A, Zemla TJ, Jatoi A, et al. Time-to-Treatment-Failure and Related Outcomes among 1000+ Advanced Non-Small Cell Lung Cancer Patients: Comparisons between Older Versus Younger Patients (Alliance A151711). J Thorac Oncol. 2018;13(7):996-1003. PMID: 29608967. PMC6015776.
  15. Geynisman DM, Meeker CR, Doyle JL, et al. Provider and Patient Burdens of Obtaining Oral Anticancer Medications. Am J Manag Care. 2018;24(4):e128-e133. PMID: 29668216.
  16. Gianti E, Delemotte L, Klein ML, Carnevale V. On the Role of Water Density Fluctuations in the Inhibition of a Proton Channel. Proc Natl Acad Sci USA. 2016;113(52):E8359-E8368. PMID: 27956641. PMC5206518.
  17. Giri VN, Obeid E, Hegarty SE, et al. Understanding of Multigene Test Results among Males Undergoing Germline Testing for Inherited Prostate Cancer: Implications for Genetic Counseling. Prostate. 2018;78(12):879-888. PMID: 29655297. PMC6047906.
  18. Gray PN, Tsai P, Chen D, et al. TumorNext-Lynch-MMR: A Comprehensive Next Generation Sequencing Assay for the Detection of Germline and Somatic Mutations in Genes Associated with Mismatch Repair Deficiency and Lynch Syndrome. Oncotarget. 2018;9(29):20304-20322. PMID: 29755653. PMC5945525.
  19. Gu J, Maxwell AE, Ma GX, et al. Evaluating the Training of Chinese-Speaking Community Health Workers to Implement a Small-Group Intervention Promoting Mammography. J Cancer Educ. 2018. PMID: 29654506.
  20. Hall TM, Tetreault MP, Hamilton KE, Whelan KA. Autophagy as a Cytoprotective Mechanism in Esophageal Squamous Cell Carcinoma. Curr Opin Pharmacol. 2018;41:12-19. PMID: 29677645. PMC6108938.
  21. Hassett MJ, Jiang W, Hughes ME, et al. Treating Second Breast Events after Breast-Conserving Surgery for Ductal Carcinoma in Situ. J Natl Compr Canc Netw. 2018;16(4):387-394. PMID: 29632058.
  22. Heckman CJ, Handorf E, Auerbach MV. Prevalence and Correlates of Skin Cancer Screening among Indoor Tanners and Nontanners. JAMA Dermatol. 2018;154(5):554-560. PMID: 29617518. PMC6128499.
  23. Hellmann MD, Ciuleanu TE, Pluzanski A, et al. Nivolumab Plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden. N Engl J Med. 2018;378(22):2093-2104. PMID: 29658845.
  24. Hellmann MD, Nathanson T, Rizvi H, et al. Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Cancer Cell. 2018;33(5):843-852 e844. PMID: 29657128. PMC5953836.
  25. Hernandez Borrero LJ, Sikder R, Lulla A, et al. Bcl-2 Protein Targeting by the P53/P21 Complex-Letter. Cancer Res. 2018;78(10):2770-2771. PMID: 29703721.
  26. Hernandez-Borrero LJ, Zhang S, Lulla A, Dicker DT, El-Deiry WS. CB002, a Novel P53 Tumor Suppressor Pathway-Restoring Small Molecule Induces Tumor Cell Death through the Pro-Apoptotic Protein NOXA. Cell Cycle. 2018;17(5):557-567. PMID: 28749203. PMC5969548.
  27. Houghton LC, Knight JA, De Souza MJ, et al. Comparison of Methods to Assess Onset of Breast Development in the Legacy Girls Study: Methodological Considerations for Studies of Breast Cancer. Breast Cancer Res. 2018;20(1):33. PMID: 29669587. PMC5907380.
  28. Ingram JP, Tursi S, Zhang T, et al. A Nonpyroptotic Ifn-Gamma-Triggered Cell Death Mechanism in Nonphagocytic Cells Promotes Salmonella Clearance in Vivo. J Immunol. 2018;200(10):3626-3634. PMID: 29654208. PMC6034694.
  29. Jalagadugula G, Goldfinger LE, Mao G, Lambert MP, Rao AK. Defective RAB1B-Related Megakaryocytic Er-to-Golgi Transport in Runx1 Haplodeficiency: Impact on Von Willebrand Factor. Blood Adv. 2018;2(7):797-806. PMID: 29632235. PMC5894258.
  30. Jonasch E, Slack RS, Geynisman DM, et al. Phase II Study of Two Weeks on, One Week Off Sunitinib Scheduling in Patients with Metastatic Renal Cell Carcinoma. J Clin Oncol. 2018;36(16):1588-1593. PMID: 29641297.
  31. Kaiser CE, Rincon Pabon JP, Khowsathit J, et al. Modulating Antibody Structure and Function through Directed Mutations and Chemical Rescue. ACS Synth Biol. 2018;7(4):1152-1162. PMID: 29609459. PMC5910032. NIHMS958000.
  32. Kamboj M, Brite J, Aslam A, et al. Artificial Differences in Clostridium Difficile Infection Rates Associated with Disparity in Testing. Emerg Infect Dis. 2018;24(3):584-587. PMID: 29460760. PMC5823336.
  33. Kasivisvanathan V, Kutikov A, Manning TG, et al. Safeguarding the Future of Urological Research and Delivery of Clinical Excellence by Harnessing the Power of Youth to Spearhead Urological Research. Eur Urol. 2018;73(5):645-647. PMID: 29128207.
  34. Kearns AC, Robinson JA, Shekarabi M, Liu F, Qin X, Burdo TH. Caspase-1-Associated Immune Activation in an Accelerated SIV-Infected Rhesus Macaque Model. J Neurovirol. 2018;24(4):420-431. PMID: 29611111.
  35. Khatri NV, Patel B, Kohli DR, Solomon SS, Bull-Henry K, Kessler CM. Lenalidomide as a Novel Therapy for Gastrointestinal Angiodysplasia in Von Willebrand Disease. Haemophilia. 2018;24(2):278-282. PMID: 29446520.
  36. Kornblum N, Zhao F, Manola J, et al. Randomized Phase Ii Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of Pre0102. J Clin Oncol. 2018;36(16):1556-1563. PMID: 29664714.
  37. Kumar S, Patel R. Neutral Theory, Disease Mutations, and Personal Exomes. Mol Biol Evol. 2018;35(6):1297-1303. PMID: 29688514. PMC5967454.
  38. McIntosh AG, Ristau BT, Ruth K, et al. Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-Yr Clinical Outcomes. Eur Urol. 2018;74(2):157-164. PMID: 29625756.
  39. Mehrazin R, Dulaimi E, Uzzo RG, et al. The Correlation between Gain of Chromosome 8q and Survival in Patients with Clear and Papillary Renal Cell Carcinoma. Ther Adv Urol. 2018;10(1):3-10. PMID: 29344091. PMC5761913.
  40. Milano RV, Viale E, Bartel MJ, Notaristefano C, Testoni PA. Resection Outcomes and Recurrence Rates of Endoscopic Submucosal Dissection (ESD) and Hybrid ESD for Colorectal Tumors in a Single Italian Center. Surg Endosc. 2018;32(5):2328-2339. PMID: 29098434.
  41. Mishra OP, Popov AV, Pietrofesa RA, Nakamaru-Ogiso E, Andrake M, Christofidou-Solomidou M. Synthetic Secoisolariciresinol Diglucoside (LGM2605) Inhibits Myeloperoxidase Activity in Inflammatory Cells. Biochim Biophys Acta Gen Subj. 2018;1862(6):1364-1375. PMID: 29524540. PMC5970065.
  42. Moore KN, Martin LP, O’Malley DM, et al. A Review of Mirvetuximab Soravtansine in the Treatment of Platinum-Resistant Ovarian Cancer. Future Oncol. 2018;14(2):123-136. PMID: 29098867.
  43. Morgans AK, Chen YH, Sweeney CJ, et al. Quality of Life During Treatment with Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. J Clin Oncol. 2018;36(11):1088-1095. PMID: 29522362. PMC5891128.
  44. Mortazavi SMJ. Commentary: Geographic Variations in the Incidence of Glioblastoma and Prognostic Factors Predictive of Overall Survival in US Adults from 2004-2013. Front Aging Neurosci. 2018;10:105. PMID: 29708188. PMC5906709.
  45. Mortazavi SMJ. Comments on “Radiological Protection for Pregnant Women at a Large Academic Medical Cancer Center”. Phys Med. 2018;47:144. PMID: 29032028.
  46. Mortazavi SMJ. Shortcomings of the Immunological Model of Carcinogenesis. Proc Natl Acad Sci USA. 2018;115(19):E4318. PMID: 29669916. PMC5949006.
  47. Mortazavi SMJ, Mortazavi G. Re: Blood Mercury Concentration in Relation to Metabolic and Weight Phenotypes Using the KNHANES 2011-2013 Data. Int Arch Occup Environ Health. 2018;91(2):247. PMID: 29273973.
  48. Peng H, Prokop J, Karar J, et al. Familial and Somatic BAP1 Mutations Inactivate ASXL1/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res. 2018;78(5):1200-1213. PMID: 29284740. PMC6167014.
  49. Perera M, Al-Hebshi NN, Perera I, et al. Inflammatory Bacteriome and Oral Squamous Cell Carcinoma. J Dent Res. 2018;97(6):725-732. PMID: 29630846.
  50. Punglia RS, Jiang W, Lipsitz SR, et al. Clinical Risk Score to Predict Likelihood of Recurrence after Ductal Carcinoma in Situ Treated with Breast-Conserving Surgery. Breast Cancer Res Treat. 2018;167(3):751-759. PMID: 29079937.
  51. Ray M, Gabunia K, Vrakas CN, et al. Genetic Deletion of IL-19 (Interleukin-19) Exacerbates Atherogenesis in IL
  52. 19(-/-)Xldlr(-/-) Double Knockout Mice by Dysregulation of Mrna Stability Protein Hur (Human Antigen R). Arterioscler Thromb Vasc Biol. 2018;38(6):1297-1308. PMID: 29674474. PMC5970062.
  53. Reese JB, Handorf E, Haythornthwaite JA. Sexual Quality of Life, Body Image Distress, and Psychosocial Outcomes in Colorectal Cancer: A Longitudinal Study. Support Care Cancer. 2018;26(10):3431-3440. PMID: 29679138.
  54. Regine WF, Winter K, Abrams RA, et al. Postresection CA19-9 and Margin Status as Predictors of Recurrence after Adjuvant Treatment for Pancreatic Carcinoma: Analysis of NRG Oncology RTOG Trial 9704. Adv Radiat Oncol. 2018;3(2):154-162. PMID: 29904740. PMC6000159.
  55. Remakus S, Ma X, Tang L, et al. Cutting Edge: Protection by Antiviral Memory CD8 T Cells Requires Rapidly Produced Antigen in Large Amounts. J Immunol. 2018;200(10):3347-3352. PMID: 29643193. PMC5940544.
  56. Ristau BT, Smaldone MC. Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines. Editorial Comment. Journal of Urology. 2018;199(4):914-914.
  57. Rudat S, Pfaus A, Cheng YY, et al. Ret-Mediated Autophagy Suppression as Targetable Co-Dependence in Acute Myeloid Leukemia. Leukemia. 2018;32(10):2189-2202. PMID: 29654265.
  58. Shah T, Lippman R, Kohli D, Mutha P, Solomon S, Zfass A. Accuracy of Probe-Based Confocal Laser Endomicroscopy (PCLE) Compared to Random Biopsies During Endoscopic Surveillance of Barrett’s Esophagus. Endosc Int Open. 2018;6(4):E414-E420. PMID: 29607393. PMC5876024.
  59. Smith EP, Li H, Friedberg JW, et al. Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703). Biol Blood Marrow Transplant. 2018;24(4):700-707. PMID: 29289757. PMC5965270.
  60. Steffen LE, Vowles KE, Smith BW, Gan GN, Edelman MJ. Daily Diary Study of Hope, Stigma, and Functioning in Lung Cancer Patients. Health Psychol. 2018;37(3):218-227. PMID: 29172604. PMC5837918.
  61. Thomson MD, Siminoff LA. Managing Work and Cancer Treatment: Experiences among Survivors of Hematological Cancer. Cancer. 2018;124(13):2824-2831. PMID: 29660822. PMC6070342.
  62. Ujjani C, Wang H, Skarbnik A, et al. A Phase 1 Study of Lenalidomide and Ibrutinib in Combination with Rituximab in Relapsed and Refractory CLL. Blood Adv. 2018;2(7):762-768. PMID: 29610115. PMC5894261.
  63. von Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. J Clin Oncol. 2018;36(2):136-143. PMID: 29220298.
  64. Wang HH, Wu ZQ, Qian D, et al. Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis in Vitro and in Vivo. Int J Radiat Oncol Biol Phys. 2018;101(1):49-62. PMID: 29619976.
  65. Wolf SM, Scholtes E, Koenig BA, et al. Pragmatic Tools for Sharing Genomic Research Results with the Relatives of Living and Deceased Research Participants. J Law Med Ethics. 2018;46(1):87-109. PMID: 30008546. PMC6040667.
  66. Wood DE, Kazerooni EA, Baum SL, et al. Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16(4):412-441. PMID: 29632061.
  67. Yadav J, Korzekwa K, Nagar S. Improved Predictions of Drug-Drug Interactions Mediated by Time-Dependent Inhibition of Cyp3a. Mol Pharm. 2018;15(5):1979-1995. PMID: 29608318. PMC5938745.
  68. Zaorsky NG, Keith SW, Shaikh T, et al. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities. Am J Clin Oncol. 2018;41(4):409-415. PMID: 27014930.
  69. Zhang BW, Cui D, Matubayasi N, Levy RM. The Excess Chemical Potential of Water at the Interface with a Protein from End Point Simulations. J Phys Chem B. 2018;122(17):4700-4707. PMID: 29634902. PMC5939383.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s